Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

Share Price is delayed by 15 minutes
Get Live Data
248.50    -1.50 (-0.60%)
Bid:
245.00
Ask:
252.00
Spread: 7.00 (2.857%)
Market Cap: £225.74m
CNC Live PriceLast checked at - London Stock Exchange

Intraday Concurrent Technologies Share Chart

Product Launch

6 Apr 2010 11:26

Concurrent Technologies Plc

Product Launch New Computer Product Augments Competitive Position

Concurrent Technologies Plc ("Concurrent" or the "Company"), a world leading specialist in the design and manufacture of high-end embedded computer products, is pleased to announce the launch of a new range of VME embedded computer boards; the VP 717/08X.

This range of boards is based on the recently launched Intel® Coreâ„¢ i7 processor which has been introduced for the mobile embedded market and is based on the very latest 32nm technology. The processor introduces key features which will be of benefit to an even wider range of applications within the defence market than previously suited to Intel® processor technology. Consequently, VP 717/08X customers will benefit from improved performance per Watt of power, a sophisticated memory cache as well as much faster memory performance and improved graphics capability. Given the high performance and increased functionality of the Coreâ„¢i7, the boards are particularly well suited for CPU intensive processing applications within the defence, homeland security, industrial control, and transportation market sectors. Commercial and extended temperature versions are available today, and a compatible range of ruggedized, conduction-cooled or air-cooled versions will be available shortly.

Glen Fawcett, Managing Director, Concurrent Technologies, commented:

"Concurrent remains committed to producing products which will be available for many years and this is no exception. We only use processors from Intel's embedded roadmap which guarantees availability for a minimum of 7 years; this goes a long way to meeting the needs of our customers' requirements for long life cycle products while simultaneously providing them with enhanced processing capabilities.

The VP 717/08x, being an upgrade to an existing board,will appeal to both existing customers for technology refreshes, as well as new customers who can take advantage of the latest features of the Coreâ„¢ i7technology to standardize more of their application on Intel®based hardware, thereby reducing their overall cost of ownership."

6 April, 2010Enquiries:Concurrent Technologies Plc 01206 752 626

Glen Fawcett, Managing Director

Haggie Financial LLP 020 7417 8989

Nicholas Nelson

Nominated AdviserBrewin Dolphin Investment Banking 0845 213 4726

Neil Baldwin/Neil McDonald

All trademarks, registered trademarks and trade names used in this announcement are the property of their respective owners.

Note to Editors:

Concurrent Technologies Plc develops and manufactures high-end embedded computer products for use in a wide range of high performance applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets. Using Intel® processors, including the latest Intel® Coreâ„¢ i7 processors, Intel® Xeon®, Atomâ„¢ and Coreâ„¢ 2 dual-core processors, the Company offers a wide range of computer products which are designed to be compliant with the most stringent industry specifications including those for products used in extremely harsh environments.

For more information on Concurrent and its products please visit http:// www.cct.co.uk

vendor
Date   Source Headline
22nd May 20183:41 pmRNSAGM Statement
21st May 20187:00 amRNSProduct Announcement
30th Apr 20189:30 amRNSDistribution of Annual Report and Accounts
4th Apr 20187:00 amRNSResults for the year ended 31 December 2017
3rd Apr 20189:01 amRNSProduct Announcement
28th Mar 20184:03 pmRNSNotice of Results
27th Mar 20182:14 pmRNSProduct Announcement
8th Mar 20187:00 amRNSSecond Interim Dividend
26th Feb 201810:17 amRNSCorrection - Product Announcement
26th Feb 20187:00 amRNSProduct Announcement
21st Feb 20187:00 amRNSProduct Announcement
23rd Jan 20187:00 amRNSProduct Announcement
21st Dec 20177:00 amRNSPre-Close Trading Update
30th Nov 20171:29 pmRNSProduct Announcement
18th Sep 20177:00 amRNSInterim Results for the six months ended 30 Jun 17
5th Sep 20177:00 amRNSNotice of Results
26th Jun 20177:00 amRNSProduct Announcement
25th May 20172:57 pmRNSResult of AGM
9th May 20177:00 amRNSNotice of AGM
12th Apr 20172:08 pmRNSDistribution of Annual Report and Accounts
30th Mar 201711:18 amRNSHolding(s) in Company
29th Mar 20174:33 pmRNSHolding(s) in Company
24th Mar 20177:00 amRNSFinal Results
22nd Mar 20177:00 amRNSNotice of Results
2nd Mar 201710:11 amRNSProduct Announcement
24th Feb 20177:00 amRNSSecond Interim Dividend
30th Jan 20179:23 amRNSProduct Announcement
13th Jan 20179:30 amRNSHolding(s) in Company
13th Jan 20179:30 amRNSHolding(s) in Company
20th Dec 20162:36 pmRNSPre-Close Trading Update
16th Dec 20163:13 pmRNSDirector/PDMR Shareholding
1st Nov 20167:00 amRNSProduct Launch
29th Sep 20167:00 amRNSProduct Launch
22nd Sep 20162:45 pmRNSTotal Voting Rights
9th Sep 201612:05 pmRNSDirector/PDMR Shareholding
30th Aug 20165:05 pmRNSHolding(s) in Company
30th Aug 201612:59 pmRNSHolding(s) in Company
26th Aug 20167:00 amRNSInterim Results
19th Aug 20162:21 pmRNSNotice of Interim Results
22nd Jul 20161:55 pmRNSHolding(s) in Company
1st Jul 20167:00 amRNSTrading Update
1st Jun 20162:43 pmRNSTotal Voting Rights
19th May 201612:56 pmRNSAGM Statement
12th May 20165:18 pmRNSDirector/PDMR Shareholding
6th May 20167:00 amRNSProduct Launch
19th Apr 20163:51 pmRNSDirector/PDMR Shareholding
19th Apr 201612:10 pmRNSDirector/PDMR Shareholding
18th Apr 20162:14 pmRNSDirector/PDMR Shareholding
18th Apr 201610:55 amRNSPosting of Annual Report & Accounts
29th Mar 20164:53 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.